Envestnet Asset Management’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $513K | Sell |
9,605
-3,729
| -28% | -$199K | ﹤0.01% | 3669 |
|
2025
Q1 | $540K | Buy |
13,334
+3,170
| +31% | +$128K | ﹤0.01% | 3577 |
|
2024
Q4 | $283K | Sell |
10,164
-544
| -5% | -$15.1K | ﹤0.01% | 3921 |
|
2024
Q3 | $307K | Buy |
+10,708
| New | +$307K | ﹤0.01% | 3808 |
|
2024
Q2 | – | Sell |
-14,427
| Closed | -$364K | – | 4165 |
|
2024
Q1 | $364K | Buy |
+14,427
| New | +$364K | ﹤0.01% | 3621 |
|
2023
Q4 | – | Sell |
-9,426
| Closed | -$477K | – | 4046 |
|
2023
Q3 | $477K | Buy |
+9,426
| New | +$477K | ﹤0.01% | 3283 |
|